Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

105Citations
Citations of this article
277Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As the field of artificial intelligence and machine learning (AI/ML) for drug discovery is rapidly advancing, we address the question “What is the impact of recent AI/ML trends in the area of Clinical Pharmacology?” We address difficulties and AI/ML developments for target identification, their use in generative chemistry for small molecule drug discovery, and the potential role of AI/ML in clinical trial outcome evaluation. We briefly discuss current trends in the use of AI/ML in health care and the impact of AI/ML context of the daily practice of clinical pharmacologists.

Cite

CITATION STYLE

APA

Zhavoronkov, A., Vanhaelen, Q., & Oprea, T. I. (2020, April 1). Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology? Clinical Pharmacology and Therapeutics. Nature Publishing Group. https://doi.org/10.1002/cpt.1795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free